With lower treatment costs, no debt to pay off, higher commodity prices and pulling out high quality ore as evidenced by the recent announcement what is everyone's thoughts on EBITDA number for the next Qtrly? We won't have the carry-over gold income and FX is slightly higher but everything else has gone our way so far. Last Qtr was 13m plus 6.5m paid back on the loan. Is an EBITDA in the 20-25m range or higher out of the question?
With lower treatment costs, no debt to pay off, higher commodity...
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)